Antithrombotic effects of Abciximab
- 15 May 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 85 (10) , 1167-1172
- https://doi.org/10.1016/s0002-9149(00)00722-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular DiseaseJAMA, 1999
- Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profileJournal of the American College of Cardiology, 1999
- Treatment with a GPIIb/IIIa Antagonist Inhibits Thrombin Generation in Platelet Rich Plasma from PatientsThrombosis and Haemostasis, 1998
- Correlation of Angiographic Morphology and Clinical Presentation in Unstable AnginaJournal of the American College of Cardiology, 1997
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996
- Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.Circulation, 1994
- Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque ruptureJournal of the American College of Cardiology, 1994
- Unstable angina. A classification.Circulation, 1989
- Guidelines for percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1988
- Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986